The major G-quadruplex formed in the human platelet-derived growth factor receptor β promoter adopts a novel

Yuwei Chen1, Prashansa Agrawal, Robert V Brown

  • 1Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, 1703 East Mabel Street, Tucson, Arizona 85721, USA.

Insights

Researchers identified a novel DNA G-quadruplex structure in the platelet-derived growth factor receptor β (PDGFR-β) gene promoter. This unique structure, with a broken G-strand, offers a new target for developing drugs to treat PDGFR-β-associated cancers and fibrotic disorders.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Overexpression of platelet-derived growth factor receptor β (PDGFR-β) is linked to cancers and fibrotic diseases.
  • PDGFR-β is a therapeutic target for these conditions.
  • DNA G-quadruplexes in the PDGFR-β promoter inhibit its transcription.

Purpose of the Study:

  • To determine the major G-quadruplex structure in the human PDGFR-β gene promoter.
  • To understand the structural features of this G-quadruplex.
  • To explore its potential as a drug target.

Main Methods:

  • Structural analysis of DNA G-quadruplexes.
  • Investigation of promoter G-quadruplex folding.
  • Bioinformatic analysis of G-quadruplex motifs.

Main Results:

  • A novel G-quadruplex structure was identified in the PDGFR-β promoter.
  • This G-quadruplex features a broken G-strand and a primarily parallel-stranded intramolecular fold.
  • It contains three 1-nucleotide (nt) double-chain-reversal loops and one lateral loop.
  • The structure highlights the stability of parallel G-quadruplexes with 1-nt loops.

Conclusions:

  • The novel PDGFR-β promoter G-quadruplex structure is a potential target for small-molecule drugs.
  • Targeting this structure could modulate PDGFR-β gene expression for therapeutic benefit.
  • The 1-nt looped G(i)NG(j) motif may be an evolutionarily selected structural element in promoter G-quadruplexes.

Related Concept Videos

Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...